ISPOR Board of Directors Service Awards

The ISPOR Board of Directors Service Awards recognize members who have served on the ISPOR Board of Directors.

ISPOR 2015 – 2017 BOARD OF DIRECTORS SERVICE AWARDS

PRESIDENT (2015-2016) & PAST PRESIDENT (2016-2017) Daniel C. Malone, RPh, PhD, Professor of Pharmacy, College of Pharmacy & Associate Professor in Mel & Enid Zuckerman College, University of Arizona Tucson, AZ, USA

DIRECTOR (2015-2017) Nancy Devlin, PhD, Director of Research, Office of Health Economics, London, UK

DIRECTOR (2015-2017) Manuel Espinoza, MD, MSc, PhD, Professor, Department of Public Health, & Chief, HTA Unit, Catholic University of Chile, Santiago, Chile and Honorary Visiting Fellow, Centre for Health Economics University of York, York, UK

DIRECTOR (2015-2017) Dana Goldman, PhD, Leonard D. Schaeffer Director's Chair, & Director, Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, CA, USA

ISPOR 2015 – 2016 BOARD OF DIRECTORS SERVICE AWARDS

PRESIDENT (2014-2015) & PAST PRESIDENT (2015-2016) Adrian Towse, MA, MPhil, Director, Office of Health Economics, London, UK
DIRECTOR (2014-2016) Karen Worley, PhD, Research Manager, Comprehensive Health Insights
Humana, Cincinnati, OH, USA
DIRECTOR (2014-2016) Josephine Mauskopf, PhD, Vice President, RTI Health Solutions, Research Triangle Park, NC, USA
DIRECTOR (2014-2016) Yen-Huei (Tony) Tarn, MS, PhD, Executive Director, Center for Pharmaceutical Care Development, Taiwan Pharmacist Association, Taipei, Taiwan
DIRECTOR (2014-2016) Dominik Tomek, PharmD, MPH, PhD, Senior Researcher, Institute of Clinical & Experimental Pharmacology Slovak Medical University, Bratislava, Slovakia
TREASURER (2013-2016) Zeba M. Khan, RPh, PhD, Vice President, Celgene Corporation, Summit, NJ, USA

ISPOR 2014 – 2015 BOARD OF DIRECTORS SERVICE AWARDS

PRESIDENT (2013-2014) & PAST PRESIDENT (2014-2015) William H. Crown, PhD, Chief Scientific Officer, Optum Labs, Cambridge, MA, USA
DIRECTOR (2013-2015) W. G. (Wim) Goettsch, MSc, PhD, Project Leader, EUnetHTA JA 2, WP 5 Rapid Assessments National Health Care Institute, Diemen, The Netherlands
DIRECTOR (2013-2015) Adrian Griffin, MSc, Vice President, HTA & Market Access Policy, Worldwide Government Affairs and Policy, Johnson & Johnson, Buckinghamshire, UK
DIRECTOR (2013-2015) Maarten J. IJzerman, PhD, Professor & Chair, Department of Health Technology and Services Research (HTSR) and Scientific Director of MIRA Institute for Biomedical Technology & Technical Medicine, University of Twente; Founder and Director PANAXEA, Enschede, The Netherlands

ISPOR 2013 – 2014 BOARD OF DIRECTORS SERVICE AWARDS

PRESIDENT (2012-2013) & PAST PRESIDENT (2013-2014) Deborah Marshall, PhD, MHSA, Canada Research Chair, Health Services and Systems Research; Associate Professor, Department of Community Health Sciences Faculty of Medicine, University of Calgary; Director, Health Technology Assessment, Alberta Bone and Joint Health Institute, Calgary, AB, Canada
DIRECTOR (2012-2014) Jan Busschbach, PhD, Professor, Health Related Quality of Life; Head, Department for Medical Psychology & Psychotherapy, Erasmus University Rotterdam; Managing Director, Viersprong Institute for Studies of Personality Disorders (VISPD) Rotterdam, Netherlands
DIRECTOR (2012-2014) Marcelo Fonseca, MD, MSc, Professor, HTA & Clinical Research, Federal University of São Paulo (UNIFESP) Director, Axia.Bio; Assistant Physician, Pediatric Intensive Care Unit, Federal University of São Paulo Faculty of Medicine Clinics Hospital, São Paulo, Brazil
DIRECTOR (2012-2014) Zoltán Kaló, MSc, MD, PhD, Director, Health Economic Research Center, Department of Health Policy and Health Economics; Associate Professor of Social Sciences Eötvös Loránd University (ELTE); Founder & CEO, Syreon Research Institute Budapest, Hungary
DIRECTOR (2012-2014) Kenneth KC Lee, MPhil, PhD, RPh, Professor of Pharmacy and Head of Pharmacy School of Medicine & Health Sciences, Monash University, Kuala Lumpur, Malaysia

ISPOR 2012 – 2013 BOARD OF DIRECTORS SERVICE AWARDS

PRESIDENT (2012-2013) Deborah Marshall, PhD, MHSA, Canada Research Chair, Health Services and Systems Research; Associate Professor, Department of Community Health Sciences Faculty of Medicine, University of Calgary; Director, Health Technology Assessment, Alberta Bone and Joint Health Institute, Calgary, AB, Canada
PAST PRESIDENT (2012-2013) Mark J. Sculpher, MSc, PhD, Professor of Health Economics Centre for Health Economics, University of York, Heslington, York, United Kingdom
DIRECTOR (2011-2013) Finn Børlum Kristensen, MD, PhD, Professor, Health Services Research & Health Technology Assessment, University of Southern Denmark; Director EUnetHTA Secretariat, Danish Health and Medicines Authority, Copenhagen, Denmark
DIRECTOR (2011-2013) Newell McElwee, PharmD, MSPH, Executive Director, Merck, North Wales, PA, USA
DIRECTOR (2011-2013)
Donald L. Patrick, PhD, MSPH, Professor, Department of Health Services and Director, Seattle Quality of Life Group & Biobehavioral Cancer Training Program, University of Washington, Seattle, WA, USA
TREASURER (2010-2013) Karen L. Rascati RPh, PhD, Turley/Eckerd Centennial Endowed Professor of Pharmacy Administration and Faculty Member, Center for Pharmacoeconomic Studies, College of Pharmacy, University of Texas, Austin TX, USA

ISPOR 2011 – 2012 BOARD OF DIRECTORS SERVICE AWARDS

PRESIDENT (2011-2012) AND PAST PRESIDENT (2012-2013) Mark J. Sculpher, MSc, PhD, Professor of Health Economics Centre for Health Economics, University of York, Heslington, York, United Kingdom
DIRECTOR (2011-2013) Finn Børlum Kristensen, MD, PhD, Professor, Health Services Research & Health Technology Assessment, University of Southern Denmark; Director EUnetHTA Secretariat, Danish Health and Medicines Authority, Copenhagen, Denmark
DIRECTOR (2011-2013) Newell McElwee, PharmD, MSPH, Executive Director, Merck, North Wales, PA, USA
DIRECTOR (2011-2013) Donald L. Patrick, PhD, MSPH, Professor, Department of Health Services and Director, Seattle Quality of Life Group & Biobehavioral Cancer Training Program, University of Washington, Seattle, WA, USA
TREASURER (2010-2013) Karen L. Rascati, RPh, PhD, Turley/Eckerd Centennial Endowed Professor of Pharmacy Administration and Faculty Member, Center for Pharmacoeconomic Studies, College of Pharmacy, University of Texas, Austin TX, USA

ISPOR 2010 – 2011 BOARD OF DIRECTORS SERVICE AWARDS

PRESIDENT (2010-2011) & PAST PRESIDENT (2011-2012) Scott D. Ramsey, MD, PhD, Member, Fred Hutchinson Cancer, Research Center; Professor, School of Pharmacy School of Medicine, Institute for Public Health Genetics, University of Washington, Seattle, Washington, USA
DIRECTOR (2010-2012) Federico Augustovski MD, MSc, PhD, Director, Economic Evaluations and HTA Department, Institute for Clinical Effectiveness and Health Policy (IECS), Professor of Public Health, University of Buenos Aires; Family and Community Medicine Division, Hospital Italiano of Buenos Aires, Buenos Aires, Argentina
DIRECTOR (2010-2012) Kati Copley-Merriman MS, MBA,Vice-President, Regulatory and Outcomes Strategy/Market Access, RTI, Ann Arbor, MI, USA
DIRECTOR (2010-2012) Johan L. (Hans) Severens, PhD, Professor, Evaluation in Health Care Institute of Health Policy and Management Erasmus University Rotterdam, Rotterdam, The Netherlands
DIRECTOR (2010-2012) Bong-Min Yang, PhD, Professor, Health Economics, School of Public Health, Seoul National University, Seoul, South Korea

ISPOR 2008 – 2011 BOARD OF DIRECTORS SERVICE AWARDEES

PRESIDENT (2009-2010) & PAST PRESIDENT (2010-2011) Michael Barry, MD, PhD, FRCPI, Clinical Director
National Centre for Pharmacoeconomics, St. James's Hospital, Dublin, Ireland
DIRECTOR (2008-2011) Paul Kind, Professor, Centre for Health Economics, Alcuin College, University of York, Heslington, York, UK
DIRECTOR (2009-2011) Ansgar Hebborn, PhD, Global Head, Economic Value Strategy, F. Hoffmann-La Roche
Basel, Switzerland
DIRECTOR (2009-2011) Shelby Reed, PhD, RPh, Duke Clinical Research Institute, Duke University, Durham, NC, USA

ISPOR 2007 – 2010 BOARD OF DIRECTORS SERVICE AWARDEES

PRESIDENT (2008-2009) & PAST PRESIDENT (2009-2010) Chris L. Pashos PhD, Vice President, United BioSource Corporation, Lexington, MA, USA
DIRECTOR (2008-2010) Shanlian Hu MD, MSc, Director and Professor, Training Center for Health Management, School of Public Health, Fudan University, Shanghai, P.R. China
DIRECTOR (2008-2010) Don Husereau BSc.Pharm, MSc, Director, Project Development, HTA Canadian Agency for Drugs & Technologies, Ottawa, Ontario, Canada
DIRECTOR (2008-2010) Zeba Khan PhD, RPh, VP, Pricing & Market Access, Celgene Corporation, Summit, NJ, USA
DIRECTOR (2008-2010) Penny Mohr MA, Vice President, Programs, Center for Medical Technology Policy

ISPOR 2006 – 2008 BOARD OF DIRECTORS SERVICE AWARDEES

PRESIDENT (2007-2008) & PAST PRESIDENT (2008-2009) Diana Brixner PhD, Professor & Executive Director, Pharmacotherapy Outcomes Research Center University of Utah College of Pharmacy, Salt lake City, UT, USA
DIRECTOR (2007-2009) Lou Garrison PhD, Pharmacotherapy Outcomes Research Center, Department of Pharmacy, University of Washington, Seattle, WA, USA
DIRECTOR (2007-2009) Richard Willke PhD, Senior Director, Head of CV/Metabolic, Urology and Respiratory Outcomes Research, Pfizer, Peapack, NJ, USA

ISPOR 2006 – 2008 BOARD OF DIRECTORS SERVICE AWARDEES

PRESIDENT (2006-2007) & PAST PRESIDENT (2007-2008) Michael F. Drummond PhD, Professor of Health Economics, University of York, York, UK
DIRECTOR (2006-2008) Marc L. Berger MD, Vice President, Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA
DIRECTOR (2006-2008) Shu-Chuen Li PhD, Professor, Chair, Head, Discipline of Pharmacy & Experimental Pharmacology, School of Biomedical Sciences, University of Newcastle, Callaghan, NSW, Australia
DIRECTOR (2006-2008) Uwe Siebert MD, MPH, MSc, ScD, Professor of Public Health, Chair of the Department of Public Health Medical Decision Making and Health Technology Assessment at the University of Health Sciences, Medical Informatics and Technology, Hall, Innsbruck, Austria

ISPOR 2006 – 2007 BOARD OF DIRECTORS SERVICE AWARDEES

Those who serve on the ISPOR Board of Directors and various committees, task forces, and Special Interest Groups (SIGs) are an integral component to the tremendous growth and expansion ISPOR has seen over the course of their terms.

PRESIDENT (2005-2006) & PAST PRESIDENT (2006-2007) Peter Neumann ScD, Professor, Tufts University School of Medicine, Director, Center for the Evaluation of Value and Risk in Health, Tufts-New England Medical Center, Institute for Clinical Research and Health Policy Studies, Boston, MA, USA
DIRECTOR (2005-2007) Joyce Cramer, Associate Research Scientist, Yale University School of Medicine, West Haven, CT, USA
DIRECTOR (2005-2007) Scott Ramsey MD, PhD, Member, Professor, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
TREASURER (2004-2007) Lorne Basskin PharmD, Pharmacy Director, HealthSouth Sunrise Rehabilitation Hospital, Cooper City, FL, USA

>ISPOR 2005 – 2006 BOARD OF DIRECTORS SERVICE AWARDEES

PRESIDENT (2004-2005) & PAST PRESIDENT (2005-2006)
Lieven Annemans MSc, PhD, Health Economist Ghent University, Senior Consultant Global Health Economic HEDM and IMS Health, Brussels, Belgium
DIRECTOR (2004-2006) Laurie Burke MPH, RPh, Director, Study Endpoints and Label Development, Office of New Drugs, CDER, FDA, Rockville, MD, USA
DIRECTOR (2004-2006) Jens Grueger PhD, Head of Pricing and Health Economics Department, Novartis Pharmaceuticals AG, Basel, Switzerland
DIRECTOR (2004-2006) Isao Kamae MD, DrPH, Professor of Biostatistics and Health Decision Sciences, Graduate School of Medicine, Kobe University, Kobe, Japan

ISPOR 2004 – 2005 BOARD OF DIRECTORS SERVICE AWARDEES

PRESIDENT (2003-2004) & PAST PRESIDENT (2004-2005)
Sean Sullivan PhD, RPh, MS, Professor and Director, University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USA
DIRECTOR (2003-2005)
Randel Richner BSN, MPH, Vice President, Federal Affairs, Reimbursement and Outcomes Planning, Boston Scientific Corp, Natick, MA, USA
DIRECTOR (2003-2005)
Marcus Wilson PharmD , President & CEO, HealthCore Inc., Wilmington, DE, USA

ISPOR 2003 – 2004 BOARD OF DIRECTORS SERVICE AWARDEES

PAST PRESIDENT (2002-2003)
Peter Davey MD, FRCP, Head of Pharmacoeconomics, University of Dundee, Dept. of Clinical Pharmacology, Ninewells Hospital & Medical School, Dundee, Scotland
DIRECTOR (2002-2004)
Kerstin (Chris) Bingefors MSc, PhD
, Associate Professor, Research Director, Biomedical Centre, Uppsala University, Dept of Pharmacy; Pharmacoepidemiology & PE, Uppsala Sweden
DIRECTOR (2002-2004)
D.S. (Pete) Fullerton PhD
, Professor (Affiliate), University of Washington, Seattle, Washington, US
DIRECTOR (2002-2004)
Mark Nuijten PhD, MD, MBA
, Director of European Business Development, MEDTAP International, Molenpad, The Netherlands
TREASURER (2001-2004)
Jean Paul Gagnon PhD
, Director, Public Policy, Aventis Pharmaceuticals Inc., Bridgewater, NJ, USA

ISPOR 2002 – 2003 BOARD OF DIRECTORS SERVICE AWARDEES

PRESIDENT (2001-2002)
Eva Lydick PhD
, Director of Epidemiology, AstraZeneca, Wilmington, DE, USA
DIRECTOR (2001-2003)
Michael Drummond PhD
, Director, University of York, Centre for Health Economics, Heslington, York, United Kingdom
DIRECTOR (2001-2003)
Brenda Motheral RPh, PhD
, Vice President, Outcomes Research, Express Scripts, Maryland Heights, M0, USA

ISPOR 2001 SERVICE AWARDEES

President (1999-2000)
Bryan R. Luce PhD, MBA, Senior Research Leader & CEO, MEDTAP International, Bethesda, MD
Director (1999-2001)
Karen Rascati RPh, PhD, Professor, University of Texas, College of Pharmacy, Austin, TX
Director (1999-2001)
Adrian Towse MA, MPhil, Director, Office of Health Economics, London, United Kingdom

ISPOR 2000 SERVICE AWARDEES

President (1998-1999) Robert S. Epstein MD, MS
Peter G. Davey MD, FRCP, 1998-2000 Executive Board Director
Diana I. Brixner RPh, PhD, 1998-2000 Executive Board Director
Gordon J. Vanscoy PharmD, MBA, 1998-2000 Executive Board Director

Service Awards Index